Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond.

Journal of Drugs in DermatologyVol. 3 Nbr. 1, January 2004

Linked as:

Summary


Articles

See the full content of this document

Extract


Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond.

Abstract

Photodynamic therapy (PDT) with topical aminolevulinic acid (ALA) is currently approved in the US and Canada for the spot treatment of non-hypertrophic actinic keratoses of the face and scalp. Dermatologists are currently using ALA-PDT on larger skin surfaces for the treatment of extensive actinic keratoses, sun damage and acne. This article reviews the safety and efficacy of large surface ALA-PDT for the treatment of actinic keratoses and photodamage. New data on the carcinogenic potential of weekly topical ALA-PDT in mice is also presented. Groups of hairless mice were treated weekly with either ALA alone, blue light alone or ALA-PDT using blue light for a total of 10 months followed by an additional 2 months or observation. Mice were examined weekly for the presence of skin tumors. Skin tumors were not observed in mice treated weekly with blue light alone, with topical application of ALA alone or with ALA-PDT.

KEYWORDS:

SKIN CANCER

ULTRAVIOLET RADIATION

PROTOPORPHYRIN IX

PHOTODYNAMIC THERAPY

**********

Introduction

Actinic keratoses (AK) are...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company